| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2754348 | Clinical Lymphoma Myeloma and Leukemia | 2014 | 7 Pages |
Abstract
The pS6:pAKT ratio could be useful as a biomarker of target inhibition by RAD001 (clinicaltrials.gov identifier: NCT00809185).
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Anjali S. Advani, Reda Z. Mahfouz, Jaroslaw Maciejewski, Lisa Rybicki, Mikkael Sekeres, Barbara Tripp, Matt Kalaycio, Jennifer Bates, Yogen Saunthararajah,